Completed

RNA Sequencing of Solid and Cystic Lesions of the Pancreas

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being collected

Procedure Data

Collected from today forward - Prospective
ProcedureDNA Samples
Who is being recruted

Cysts+2

+ Digestive System Diseases

+ Neoplasms

Over 18 Years
+7 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Cohort

Tracking disease incidence in order to identify risk factors and understand disease progression over time.
Observational
Study Start: December 2012
See protocol details

Summary

Principal SponsorOregon Health and Science University
Last updated: January 10, 2020
Sourced from a government-validated database.Claim as a partner

Study start date: December 1, 2012

Actual date on which the first participant was enrolled.

The nature of cysts and solid masses in the pancreas can be difficult to diagnose. They may be benign, precancerous, or cancer. Current tests such as cytology (looking under a microscope) and tumor markers do not always give us the answer. The investigators are looking for genetic markers on biopsy specimens from the pancreas that will give us a better test for diagnosis. This study is only for diagnosing these lesions. The investigators are not treating any patients.

Principal SponsorOregon Health and Science University
Last updated: January 10, 2020
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

72 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Cohort

These studies follow a group of individuals with common characteristics (such as a condition or birth year) over a specific period to study health outcomes or exposures.


Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Over 18 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

CystsDigestive System DiseasesNeoplasmsPancreatic DiseasesPancreatic Cyst

Criteria

4 inclusion criteria required to participate
greater than 18 years old

have a cyst or mass of the pancreas needing diagnosis

not pregnant

referred for endoscopic ultrasound

3 exclusion criteria prevent from participating
less than age 18

no mass or cyst found

pregnant

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

One single intervention group is designated in this study

This study does not include a placebo group 

Treatment Groups

Study Objectives

Primary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 2 locations

Providence St Vincent Hospital

Portland, United StatesOpen Providence St Vincent Hospital in Google Maps

Oregon Health and Science University

Portland, United States
Completed2 Study Centers